Petros Pharmaceuticals, Inc. (PTPI) Revenue 2020–2024
Petros Pharmaceuticals, Inc. (PTPI) annual revenue history from SEC filings — each fiscal year as reported, with year-over-year change.
$5.1MFY2024 · since FY2020: $9.6M → $5.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | $5.1M | -12.2% |
| FY2023 | $5.8M | -2.8% |
| FY2022 | $6.0M | -23.3% |
| FY2021 | $7.8M | -18.3% |
| FY2020 | $9.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice